Top Markets
Coin of the day
MedX Health Corp MedX Health Corp

MedX Health Corp

MDXHF
Rangering i aksjer #33183
MedX Health Corp is a medical technology company specializing in both... MedX Health Corp is a medical technology company specializing in both diagnostic tools and therapeutic devices. The firm develops, manufactures, and markets advanced solutions for skin screening and light-based therapy, serving customers across Canada, the United States, and international markets. Its diagnostic portfolio includes SIAscopy, a cutting-edge medical device technology designed to scan skin for early detection of suspicious moles and lesions. MedX also offers a suite of imaging systems – SIAMETRICS, SIMSYS, and MoleMate – which provide real-time visuals, allowing physicians and dermatologists to rapidly assess various types of moles and lesions. On the therapeutic side, MedX produces phototherapeutic medical devices. These devices employ low-level laser and LED light energy to address pain relief and promote tissue repair, primarily within the rehabilitation sector. To enhance accessibility, MedX operates the DermSecure telemedicine platform. This web-based system enables the remote operation of its SIAscopy technology, facilitating the deployment of its diagnostic tools in a network of third-party locations. Through DermSecure, patient images of moles and lesions, alongside other relevant clinical data, can be securely transmitted to specialist physicians for expert remote assessment. The company was founded in 1999 and its headquarters are situated in Mississauga, Canada.
Aksjekurs
$0.025
Sist synkronisert: 2026-08-13
Markedsverdi
$8.20M
Endring (1 dag)
0.00%
Endring (1 år)
3,025.00%
Land
CA
Handel MedX Health Corp (MDXHF)

Kategori

P/E-forhold for MedX Health Corp (MDXHF)
P/E-forhold per 2026 TTM: 0
Ifølge MedX Health Corp sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/E-forhold (TTM) 0. Ved slutten av 2026 hadde selskapet en P/E på 0.
P/E-forholdshistorikk for MedX Health Corp fra 2026 til 2026
P/E-forhold ved slutten av hvert år
År P/E-forhold Endre
Ikke nok data for de angitte datoene.
P/E-forhold for lignende selskaper eller konkurrenter
Selskap P/E-forhold Forskjell i P/E-forhold Land
35.77 -
US
34.86 -
US
21.39 -
IE
20.90 -
US
52.64 -
US
Hvordan lese en P/E-ratio?

Pris/inntjening-forholdet (P/E) måler forholdet mellom aksjekursen og inntjening per aksje.
En lav men positiv P/E indikerer høy inntjening sammenlignet med nåværende verdsettelse, og kan tyde på at selskapet er undervurdert. En høy negativ (nær 0) P/E indikerer store tap.

Selskaper med P/E over 30 eller negativ betraktes vanligvis som "vekstaksjer", hvor investorer forventer vekst eller fremtidig lønnsomhet.

Selskaper med en positiv P/E under 10 anses vanligvis som "verdiaksjer", det vil si at selskapet allerede er lønnsomt, men har begrenset vekstpotensial.